Is SCYNEXIS Inc (SCYX) Stock at the Top of the Drug Manufacturers

SCYNEXIS Inc (SCYX) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. SCYX received an overall rating of 76, which means that it scores higher than 76 percent of all stocks. SCYNEXIS Inc also achieved a score of 98 in the Drug Manufacturers - Specialty & Generic industry, putting it above 98 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 108 out of the 148 industries.

SCYX has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on SCYX!

See Full SCYX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 76 means the stock is more attractive than 76 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With SCYNEXIS Inc Stock Today?

SCYNEXIS Inc (SCYX) stock is trading at $1.78 as of 9:37 AM on Monday, Sep 25, a loss of -$1.53, or -46.3% from the previous closing price of $3.31. The stock has traded between $1.76 and $1.96 so far today. Volume today is light. So far 205,727 shares have traded compared to average volume of 474,616 shares. Click Here to get the full Stock Report for SCYNEXIS Inc stock.